Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06045923 · ClinicalTrials.gov registry record
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
A clinical trial of HIV Infections and AIDS, sponsored by Centers for Disease Control and Prevention.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06045923: Recruiting study of HIV Infections and AIDS, sponsored by Centers for Disease Control and Prevention.
NCT06045923 is a study of HIV Infections and AIDS that is actively recruiting participants, run by Centers for Disease Control and Prevention. The registered enrollment target is 100 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06045923, a study of HIV Infections and AIDS, is actively recruiting participants, sponsored by Centers for Disease Control and Prevention.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the extent of mpox viral spread and immunologic markers in people with advanced HIV. Study findings will enhance knowledge of mpox pathogenesis in severely immunocompromised people, which can inform treatment and prevention of severe illness and deaths associated with mpox in people with advanced HIV.
Primary Outcome
Monkeypox virus persistence in different sample types (including lesion, oropharyngeal, and rectal swabs; blood) over the course of illness
Conditions Studied
Study Locations (1)
Georgia
- Centers for Disease Control and Prevention - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2026-10-01 |
What NCT06045923 shows while recruiting
NCT06045923 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (78% lower).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT06045923 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06045923 about?
NCT06045923 is a clinical study titled "Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV". The purpose of this study is to examine the extent of mpox viral spread and immunologic markers in people with advanced HIV. Study findings will enhance knowledge of mpox pathogenesis in severely immunocompromised people, which can inform treatment and prevention of severe illness and deaths associa...
What is the current status of trial NCT06045923?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-03-17. Estimated completion is 2026-10-01.
What conditions does trial NCT06045923 study?
This clinical trial studies the following conditions: HIV Infections, AIDS, Monkeypox.
Who is sponsoring clinical trial NCT06045923?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06045923 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06045923's enrollment target sits among peer trials
100 267th of 542 higher than 267 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI